Augmedix, Inc. (AUGX)
Augmedix, Inc. operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in San Francisco, CA, US. The stock last traded at $2.35, down 0.21% on the session, giving a market capitalisation of $115.9M. On trailing twelve-month figures it carries a trailing P/E of -5.33, a net margin of -42.7%. Its beta of -0.19 implies it has historically moved less than the broad market.
Augmedix, Inc. is a U.S.-based company specializing in remote medical documentation and offering live support to clinical professionals. Its comprehensive platform, comprising Augmedix Live and Augmedix Notes, streamlines the entire documentation process for patient encounters. This includes preparatory tasks like pre-charting and digitizing historical patient data prior to appointments. During the consultation, it generates essential medical notes, flags care gaps, provides HCC reminders, and produces after-visit summaries. Post-visit, the system facilitates crucial administrative duties such as medical coding, processing orders, and managing referrals. Clinicians can readily access these applications via mobile devices, including smartphones or specialized wearables like Google Glass. The company's clientele primarily consists of various health systems and distinct specialty groups. Founded in 2013, Augmedix maintains its corporate headquarters in San Francisco, California.
Augmedix, Inc. is most often compared with the following Healthcare names: